drugset / Trial / NCT03802526
Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the pharmacokinetics and safety/tolerability between NVP-1805-R1 and NVP-1805-R2
Timeline
- Start
- 2019-04-03
- Primary completion
- 2019-07-04
- Completion
- 2019-09-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | 10 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 20 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 80 mg | Oral |
Indications
No indication recorded.